Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,846 | -2,118 | -1,262 | -6,244 | -4,338 |
| Depreciation Amortization | 633 | 464 | 268 | 2,365 | 1,766 |
| Accounts receivable | 49 | 69 | 70 | -95 | N/A |
| Other Working Capital | 507 | 421 | 264 | 654 | 17 |
| Other Operating Activity | 68 | 21 | -6 | 1,546 | 1,054 |
| Operating Cash Flow | $-1,589 | $-1,143 | $-666 | $-1,774 | $-1,501 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -154 | -153 | -157 | -347 | -129 |
| Purchase Of Investment | -4 | -4 | -7 | N/A | -4 |
| Investing Cash Flow | $-158 | $-157 | $-164 | $-347 | $-133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 673 | 673 |
| Debt Repayment | 95 | 27 | 11 | N/A | N/A |
| Common Stock Issued | 1,637 | 1,244 | 733 | 1,964 | 1,275 |
| Other Financing Activity | -50 | 0 | 0 | -490 | -133 |
| Financing Cash Flow | $1,682 | $1,271 | $744 | $2,147 | $1,815 |
| Beginning Cash Position | 86 | 86 | 86 | 60 | 60 |
| End Cash Position | 21 | 57 | N/A | 86 | 241 |
| Net Cash Flow | $-65 | $-29 | $-86 | $26 | $181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,589 | -1,143 | -666 | -1,774 | -1,501 |
| Capital Expenditure | -154 | -153 | -157 | -347 | -129 |
| Free Cash Flow | -1,743 | -1,296 | -823 | -2,121 | -1,630 |